Two or three issues side by side. Only issues that are open, upcoming or awaiting listing appear — those are the ones a comparison can act on, and the ones whose figures are actually published.
3 is the most that fits side by side. Remove one to add another.
| Comparing | TI Tempsens Instruments (India) LimitedMainboard · Upcoming | SP Symbiotec PharmalabMainboard · Upcoming | SI Skytech Infinite Platform LimitedSME · Closed |
|---|---|---|---|
| Issue | |||
| Board | Mainboard | Mainboard | SME |
| Status | Upcoming | Upcoming | Closed |
| Price band | ₹285 – ₹300 | ₹988 | ₹73 – ₹77 |
| Lot size | 50 shares | — | |
A row is shown only where at least one of these issues has published the figure; a dash means that company has not. Nothing here is a recommendation — CAPITA1 is not registered with SEBI as an investment adviser or a research analyst.
| — |
| Minimum investmentOne lot at the upper band | ₹15,000 | — | — |
|---|
| Issue size | ₹650 Cr | — | ₹22.68 Cr |
|---|
| Face value | ₹4 | — | ₹10 |
|---|
| Registrar | KFin Technologies Limited | — | Integrated Registry Management Services Private Limited |
|---|
| Timeline | |||
|---|---|---|---|
| Open date | 20 Aug 2026 | 24 Aug 2026 | 14 Aug 2026 |
| Close date | 24 Aug 2026 | 27 Aug 2026 | 18 Aug 2026 |
| Allotment date | 25 Aug 2026 | 28 Aug 2026 | 19 Aug 2026 |
| Listing date | 27 Aug 2026 | 1 Sep 2026 | 21 Aug 2026 |
| Valuation | |||
|---|---|---|---|
| P/E ratioAt the upper band. Null where earnings are negative. | 35.93x | 51.73x | 12.58x |
| EPS | ₹8.35 | ₹19.1 | ₹6.12 |
| NAV per share | ₹61.66 | ₹184.69 | ₹27.66 |
| Return on equity | 13.54% | 11.19% | 22.11% |
| Return on net worth | 13.55% | 9.48% | 22.11% |
| Return on capital employed | 21.61% | 11.56% | 25.45% |
| EBITDA margin | 24.83% | 26.59% | 12.87% |
| Debt to equity | 0.15 | — | 0.49 |
| Market | |||
|---|---|---|---|
| Grey market premiumUnofficial estimate — not an exchange price | — | — | ₹1 (+1.3%) |
| Subscribed (overall) | 0.00x | — | — |